A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells

Abstract excerpt

Glioblastoma (GBM) is among the most lethal of all cancers. GBM consist of a heterogeneous population of tumor cells among which a tumor-initiating and treatment-resistant subpopulation, here termed GBM stem cells, have been identified as primary therapeutic targets. Here, we describe a high-throughput small molecule screening approach that enables the identification and characterization of chemical compounds...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to FOXO transcription factor regulation
• Share to Glioma Diagnosis and Treatment
• Share to Protein Degradation and Inhibitors